1.73

1.73 (-2.93%)

As of Feb 09, 2023

CHIMERIX INC [CMRX]

Source: 

Company Overview

Chimerix is a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. In June 2021, the U.S. Food and Drug Administration (FDA) approved TEMBEXA (brincidofovir) for the treatment of smallpox as a medical countermeasure. Our two most advanced clinical-stage development programs are ONC201 and dociparstat sodium (DSTAT). ONC201 is in development for recurrent H3 K27M-mutant glioma as its lead indication. DSTAT is in Phase 3 development as a potential first-line therapy in combination with standard chemotherapy for the treatment of acute myeloid leukemia (AML).

CountryUS
Headquartersdurhamnorth carolina
Phone Number(919) 806-1074
Industrypharmaceutical preparations
CEOMichael A. Sherman
Websitechimerix.com